Xencor


Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Industries

Employees

201-500

Links


Org chart

Bassil I. Dahiyat
President, CEO & Director
Collapse
John R. Desjarlais
EVP, Research & Chief Scientific Officer
Nancy Valente
EVP & Chief Development Officer
John J. Kuch
SVP & CFO
Celia Eckert
SVP, General Counsel & Corporate Secretary
Kirk Rosemark
SVP, Regulatory Affairs & Quality Assurance
Norman Barlow
Senior Vice President
Dane Leone
Evp, Chief Strategy Officer
Bart Cornelissen
Chief Financial Officer
Eric P. Kowack
SVP, Program Leadership & Alliance Management
Matthew Bernett
Executive Director
Tami See
Director, Clinical Data Management

Board & advisors